Filter Results:
(2,358)
Show Results For
- All HBS Web
(5,040)
- People (16)
- News (1,906)
- Research (2,358)
- Events (2)
- Multimedia (222)
- Faculty Publications (1,873)
Show Results For
- All HBS Web
(5,040)
- People (16)
- News (1,906)
- Research (2,358)
- Events (2)
- Multimedia (222)
- Faculty Publications (1,873)
Sort by
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- July 2019 (Revised October 2022)
- Case
Jai Vakeel Foundation: Addressing Disability
By: V. Kasturi Rangan and Kairavi Dey
Jai Vakeel, a nonprofit organization in India, serves individuals with Intellectual Disability (ID), those with an IQ below 70. The organization was founded by the parents of a child with Down Syndrome, and they (and their next generation) steadily built the... View Details
Keywords: Social Enterprise; Nonprofit Organizations; Transition; Growth and Development Strategy; Organizational Change and Adaptation; Family Business; Health Care and Treatment; India
Rangan, V. Kasturi, and Kairavi Dey. "Jai Vakeel Foundation: Addressing Disability." Harvard Business School Case 520-010, July 2019. (Revised October 2022.)
- 29 May 2018
- First Look
New Research and Ideas, May 29, 2018
312-032 Note on Bundled Payment in Health Care The note explains how bundled health care payment differs from fee-for-service payment, provides... View Details
Keywords: Dina Gerdeman
- 26 Jun 2012
- First Look
First Look: June 26
by a public health organization are randomly allocated to four groups. Agents in the control group receive a standard volunteer contract often offered for this type of task, whereas agents in the three treatment groups receive small... View Details
Keywords: Sean Silverthorne
- December 2007 (Revised July 2009)
- Case
Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?
GI has developed a revolutionary video pill for imaging the small bowel in the gastro-intestinal tract. The development has required the integration of wide variety of technologies. GI founder and CEO Gabriel Meron must determine GI's marketing strategy and prioritize... View Details
Keywords: Medical Specialties; Globalized Markets and Industries; Decisions; Technological Innovation; Marketing Strategy; Market Entry and Exit; Entrepreneurship; Health Care and Treatment; Corporate Finance; Medical Devices and Supplies Industry; Japan; United States; Europe
Isenberg, Daniel J. "Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?" Harvard Business School Case 808-033, December 2007. (Revised July 2009.)
- August 2023
- Case
Augmenix: Space to Think Differently
By: Satish Tadikonda and Sidhant Jena
Amar Sawhney, a serial medtech entrepreneur, had founded Augmenix to develop and commercialize a hydrogel-based medical device called SpaceOAR as an adjunctive technology to core radiation therapy. This technology was used to protect organs at risk (OAR) during... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Technology Adoption; Innovation Strategy; Technological Innovation; Product Development; Commercialization; Medical Devices and Supplies Industry
Tadikonda, Satish, and Sidhant Jena. "Augmenix: Space to Think Differently." Harvard Business School Case 824-031, August 2023.
- March 2010 (Revised April 2010)
- Case
Deworming Kenya: Translating Research into Action (A)
By: Nava Ashraf, Neil Buddy Shah and Rachel Gordon
Karen Levy and her colleague, Margaret Ndanyi, have spent the last six months planning and preparing for a national Kenyan program to target school children most at risk for parasitic worm infection. One week after its launch, the program seemed to be going well but... View Details
Keywords: Planning; Risk and Uncertainty; Mission and Purpose; Performance Efficiency; Programs; Problems and Challenges; Research; Policy; Health Care and Treatment; Management Practices and Processes; Kenya
Ashraf, Nava, Neil Buddy Shah, and Rachel Gordon. "Deworming Kenya: Translating Research into Action (A)." Harvard Business School Case 910-001, March 2010. (Revised April 2010.) (Request a courtesy copy.)
- July 2000 (Revised November 2001)
- Case
Catalyst Medical Solutions
By: Amy C. Edmondson, Richard M.J. Bohmer and Naomi Atkins
Faced with a drop in the NASDAQ, four eHealth entrepreneurs must decide between two distribution strategies for their new company's technology. The team, comprised of three full-time resident physicians and an MBA, has developed software to enable electronic... View Details
Keywords: Product Development; Health Care and Treatment; Distribution; Strategy; Venture Capital; Applications and Software; Partners and Partnerships; Borrowing and Debt; Information Technology Industry; Service Industry
Edmondson, Amy C., Richard M.J. Bohmer, and Naomi Atkins. "Catalyst Medical Solutions." Harvard Business School Case 601-014, July 2000. (Revised November 2001.)
- 27 Aug 2014
- Lessons from the Classroom
Learning From Japan’s Remarkable Disaster Recovery
executives at dozens of organizations—Google and Yahoo!, health care organizations, even a knitting business in a fishing village. They've talked with public officials in Japan and the staff of the US... View Details
- September 2021 (Revised October 2022)
- Supplement
Hester Pharmaceuticals (B): Securing Supply
By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was... View Details
Keywords: COVID-19 Pandemic; Cost vs Benefits; Trade; Supply Chain; Global Strategy; Buildings and Facilities; Operations; Health Care and Treatment; Demand and Consumers; Global Range; Globalized Markets and Industries; Pharmaceutical Industry; Italy; China; United States; Germany
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (B): Securing Supply." Harvard Business School Supplement 722-009, September 2021. (Revised October 2022.)
- 09 Nov 2010
- First Look
First Look: November 9, 2010
http://ssrn.com/abstract=1681682 CREATING LEADERS WORKSHOP: Mastering the Principles and Effective Delivery of 'The Ontological Leadership Course' (PDF File of PowerPoint Slides) Authors:Werner Erhard, Michael C. Jensen, Kari L. Granger,... View Details
Keywords: Sean Silverthorne
- 11 Feb 2019
- Research & Ideas
The Business of Saving the Planet
"The fact that the benefits of addressing the problem of climate change almost certainly outweigh the costs ... does not make concerted global action to address the problem easy." —Climate Change in 2018: Implications for Business If there is one positive... View Details
- 08 Apr 2016
- Research & Ideas
How to Hire a Millennial
General Electric isn’t moving to Boston’s waterfront for the views, however breathtaking they may be. In the increasingly fierce battle for millennial talent, GE’s decision to uproot its long-time headquarters from suburban Connecticut is nothing less than a... View Details
Keywords: by Joseph Fuller
- 07 Sep 2011
- First Look
First Look: Sept. 7
Crisis in Health Care Authors:Robert S. Kaplan and Michael E. Porter Publication:Harvard Business Review 89, no. 9 (September 2011) Abstract Existing health View Details
Keywords: Sean Silverthorne
- 10 Nov 2003
- Research & Ideas
The Hard Numbers on Social Investments
to social problems through market solutions, the rate of return on these deals should be at least as high as traditional early stage investments. The big winners were in the technology and health care... View Details
Keywords: by Manda Salls
- 2007
- Book
Perspectives on Risk and Regulation: The FDA at 100
By: Arthur A. Daemmrich and Joanna Radin
Perspectives on Risk and Regulation: The FDA at 100 brings together the viewpoints of Food and Drug Administration officials and industry leaders on the future of regulating food, drugs, medical devices, and dietary supplements. In a period of rapid scientific... View Details
Keywords: Private Sector; Governing Rules, Regulations, and Reforms; Policy; Health Care and Treatment; Business and Government Relations; Risk and Uncertainty; Cooperation
Daemmrich, Arthur A., and Joanna Radin, eds. Perspectives on Risk and Regulation: The FDA at 100. Chemical Heritage Foundation, 2007. (Fulltext.)
- 2024
- Working Paper
Cephalosporins—Fighting Hospital Infections: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant Datar and Katherine Stebbins
This case history describes the development of three generations of cephalosporins – antibiotics that have significantly reduced hospital infections. Specifically, we chronicle how: 1) Early (pre-cephalosporin) antibiotics were developed in the first half of the 20th... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant Datar, and Katherine Stebbins. "Cephalosporins—Fighting Hospital Infections: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-133, July 2020. (Revised May 2024.)
- 2024
- Working Paper
Tamoxifen—Reducing Breast Cancer Risks: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant Datar and Katherine Stebbins
We describe the development of tamoxifen, considered a “gold standard” treatment for
millions of breast cancer patients. Specifically, we describe breast cancer treatments before tamoxifen’s
development; the initial development of tamoxifen from 1960 to 1973;... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation and Invention; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant Datar, and Katherine Stebbins. "Tamoxifen—Reducing Breast Cancer Risks: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-134, July 2020. (Revised May 2024.)
- 2024
- Working Paper
Laparoscopy—Minimally Invasive Surgery: Case Histories of Transformational Advances
By: Amar Bhidé, Caitlin N. Bowler and Srikant M. Datar
We describe how operations through laparoscopes – tubular instruments inserted into abdominal cavities – revolutionized gynecological and other surgeries inside the abdomen, such as gall bladder removal. Specifically, we chronicle the 1) foundational contributions of... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Caitlin N. Bowler, and Srikant M. Datar. "Laparoscopy—Minimally Invasive Surgery: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-008, July 2019. (Revised May 2024.)
- 2025
- Working Paper
Computed Tomography (CT)--Beyond Traditional X-Rays: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how Computed Tomography (CT) scanners - that combine Xrays
and computers to image soft tissues of the brain and other organs -- have become a widely used
diagnostic tool. Specifically, we chronicle the 1) initial development of CT... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Computed Tomography (CT)--Beyond Traditional X-Rays: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-004, July 2019. (Revised January 2025.)